BIotech sector seems to be starting a new bullish phaseAccording to the CEO of NVDA, the next big revolution is coming into biotech. Biology will be engineered and therefore will compound exponentially. Now might be a good time to enter this field.
Key stats
About ARK Genomic Revolution ETF
Expense ratio
0.75%
Home page
Inception date
Oct 31, 2014
ISIN
US00214Q3020
ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. Such companies are those that may develop, produce or enable targeted therapeutics, bioinformatics, stem cells or molecular diagnostics. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund which employs an actively-managed strategy, hence investors should look closely at where the fund makes its bets before investing.
Classification
What's in the fund
Exposure type
Health Technology
Technology Services
Stock breakdown by region
Have to try a long hereRSI massively oversold on daily, macd showing bullish divergences, shark harmonic completed, doji candle, at an inflection point from a prior major swing high near the beginning of this asset...
I havent been able to hold this more than a few days in the past, hopefully this times different.
Ready
Completed harmonic, bullish divI am long here. were at a great support, completed harmonic and bullish div on the macd.
When I look at this basic trendlineI cannot help but get FOMO.
I dont know much about genomics but some very smart people make some very bold statements on where this is all heading.
Anyone that knows anything want to chime in here? why will this not moon right now?
ARKG back to its long term bottom trend; ready to run again!As markets are about to buy tech again, bio technologies are set to capture the imagination and dreams of investoors.
the upside is virtually unlimited, but a priceless prize lies somewhere ahead in the mist of this treacherous mix of money and biological researches: the Fountain of Youth.
A price
Growth Stock Cyclic Indicator [@PierceARK] The $T10YFF and $T5YFF, or 10 and 5 year treasury constant maturity minus federal funds rate is a good indicator of how likely it is that capitally intensive growthy stocks will rise in price. This is because investors cycle in/out of bonds/equities as the rates change.
You can see in the chart be
ARKG $ARKG Initial LongARKG $ARKG Initial Long. TP and SL on chart. Move SL on TP. After TP2, trail with 0.5ATR step and 1.5ATR offset.
Return to normalI feel like in a few years from now this could go up from where we are now. Nobody believes in cathie wood anymore but genomics is the future. But this got way ahead of itself. I don't expect this to moon anytime soon also
$ARKG - Weekly TF AnalysisThe macro count is pretty clear. We're below the 38.2% fib of the impulsive move from the covid lows, and approaching the 50% fib as well as the bottom of the channel. The weekly RSI is lower then even the covid lows of march 2020. In fact the RSI hasn't been this low since inception in 2016.
As w
Apocalypse of ARK invest, a forcast that became a reality..!Jim Simons:
“Scientists and mathematicians are trained to dig below the surface of the chaotic, natural world to search for unexpected simplicity, structure, and even beauty.
On February 28th, 2021 (10 months ago) I published this article:
The Social Media Trading Bubble comes to its end..!
See all ideas